Advertisement
UK markets closed
  • FTSE 100

    8,354.40
    +40.73 (+0.49%)
     
  • FTSE 250

    20,471.12
    +58.04 (+0.28%)
     
  • AIM

    779.65
    +3.23 (+0.42%)
     
  • GBP/EUR

    1.1626
    +0.0002 (+0.02%)
     
  • GBP/USD

    1.2501
    -0.0008 (-0.07%)
     
  • Bitcoin GBP

    49,772.89
    -1,218.12 (-2.39%)
     
  • CMC Crypto 200

    1,318.85
    +24.18 (+1.87%)
     
  • S&P 500

    5,181.25
    -6.45 (-0.12%)
     
  • DOW

    38,961.44
    +77.18 (+0.20%)
     
  • CRUDE OIL

    79.02
    +0.64 (+0.82%)
     
  • GOLD FUTURES

    2,326.70
    +2.50 (+0.11%)
     
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     
  • DAX

    18,488.07
    +58.02 (+0.31%)
     
  • CAC 40

    8,137.57
    +61.89 (+0.77%)
     

Eli Lilly’s Valuation on May 17

Eli Lilly’s Valuation on May 17

Eli Lilly (LLY) reported EPS of $1.34 and revenues of $5.7 billion in the first quarter. Both results surpassed Wall Street analysts’ estimates.